[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2582 Introduced in House (IH)]
107th CONGRESS
1st Session
H. R. 2582
To combat the trafficking, distribution, and abuse of Ecstasy (and
other club drugs) in the United States.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 20, 2001
Mr. Mica (for himself, Mr. Davis of Illinois, Mr. Ose, Mr. Graves, and
Mr. Keller) introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
the Judiciary, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To combat the trafficking, distribution, and abuse of Ecstasy (and
other club drugs) in the United States.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Ecstasy Prevention Act of 2001''.
SEC. 2. FINDINGS.
Congress makes the following findings:
(1) The illegal importation and use of 3,4-methylenedioxy
methamphetamine (referred to in this Act as ``MDMA'' or
``Ecstasy'') has increased more than 400 percent during the
past 3 years, as evidenced by Ecstasy seizures by the United
States Customs Service.
(2) Some research has indicated that the use of Ecstasy can
cause long-lasting and perhaps permanent damage to the
serotonin system of the brain, and can cause long-term problems
with learning and memory.
(3) Due to the popularity and marketability of Ecstasy, and
the skyrocketing use, seizures, and deaths, greater emphasis
needs to be placed on--
(A) the education of young people on the negative
health effects of Ecstasy (and other club drugs) since
the reputation of Ecstasy as a ``safe drug'' is its
most dangerous component;
(B) the education of State and local law
enforcement agencies and health care professionals and
personnel regarding the growing problem of Ecstasy use
and trafficking;
(C) adequate funding for the National Institutes of
Health to support and report on research that documents
the health effects of Ecstasy use; and
(D) State and local government initiatives.
SEC. 3. GRANTS FOR ECSTASY ABUSE PREVENTION.
Section 506B(c) of title V of the Public Health Service Act is
amended by adding at the end the following:
``(3) Effective programs.--
``(A) In general.--In addition to the priority
under paragraph (2), the Administrator shall give
priority to communities that have taken measures to
combat club drug use, including passing ordinances
restricting rave clubs, increasing law enforcement on
Ecstasy, and seizing lands under nuisance abatement
laws to make new restrictions on an establishment's
use.
``(B) State priority.--A priority grant may be made
to a State under this paragraph on a pass-through basis
to an eligible community.''.
SEC. 4. COMBATING ECSTASY AND OTHER CLUB DRUGS IN HIGH INTENSITY DRUG
TRAFFICKING AREAS.
(a) Program.--
(1) In general.--The Director of the Office of National
Drug Control Policy shall use amounts available under this
section to combat the trafficking of MDMA in areas designated
by the Director as high intensity drug trafficking areas.
(2) Activities.--In meeting the requirement in paragraph
(1), the Director shall transfer funds to assist anti-Ecstasy
law enforcement initiatives in high intensity drug trafficking
areas, including assistance for investigative costs,
intelligence enhancements, technology improvements, and
training.
(b) Authorization of Appropriations.--
(1) In general.--There are authorized to be appropriated to
carry out this section--
(A) $15,000,000 for fiscal year 2002; and
(B) such sums as may be necessary for each of the
fiscal years 2003 through 2005.
(2) No supplanting.--Any Federal funds received under this
section shall be used to supplement, not supplant, non-Federal
funds that would otherwise be used to carry out activities
funded under this section.
(c) Apportionment of Funds.--The Director shall apportion amounts
appropriated for a fiscal year pursuant to the authorization of
appropriations in subsection (b) for activities under subsection (a)
among and within areas designated by the Director and based on the
threat assessments submitted by individual high intensity drug
trafficking areas.
SEC. 5. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN.
(a) In General.--In conducting the national media campaign under
section 102 of the Drug-Free Media Campaign Act of 1998 (112 Stat.
2681-752), the Director of the Office of National Drug Control Policy
shall ensure that such campaign addresses the reduction and prevention
of abuse of MDMA and club and emerging drugs among young people in the
United States.
(b) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section--
(1) $7,000,000 for fiscal year 2002; and
(2) such sums as are necessary for each of the fiscal years
2003 through 2005.
SEC. 6. MDMA DRUG TEST.
There are authorized to be appropriated to the Office of National
Drug Control Policy such sums as are necessary to commission a drug
test for MDMA which would meet the standards for the Federal workplace.
SEC. 7. NATIONAL INSTITUTE ON DRUG ABUSE REPORT.
(a) Research.--The Director of the National Institute on Drug Abuse
(referred to in this section as the ``Director'') shall conduct
research--
(1) that evaluates the effects that MDMA use can have on an
individual's health, such as--
(A) physiological effects such as changes in
ability to regulate one's body temperature, stimulation
of the cardiovascular system, muscle tension, teeth
clenching, nausea, blurred vision, rapid eye movement,
tremors, and other such conditions, some of which can
result in heart failure or heat stroke;
(B) psychological effects such as mood and mind
altering and panic attacks which may come from altering
various neurotransmitter levels such as serotonin in
the brain;
(C) short-term effects like confusion, depression,
sleep problems, severe anxiety, paranoia,
hallucinations, and amnesia; and
(D) long-term effects on the brain with regard to
memory and other cognitive functions, and other medical
consequences; and
(2) documenting those research findings and conclusions
with respect to MDMA that are scientifically valid and identify
the medical consequences on an individual's health.
(b) Interim Report.--Not later than January 1, 2003, the Director
shall provide an interim report on the progress and current findings of
the study required by this section.
(c) Final Report.--Not later than January 1, 2004, the Director
shall submit a report to the Congress.
(d) Reports Public.--The report required by this section shall be
made public.
(e) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section--
(1) $100,000 for the interim assessment under subsection
(b); and
(2) $1,500,000 for the final report under subsection (c).
SEC. 8. INTERAGENCY ECSTASY/CLUB DRUG TASK FORCE.
(a) Establishment.--
(1) In general.--The Director of the Office of National
Drug Control Policy shall establish a Task Force on Ecstasy/
MDMA and Emerging Club Drugs (referred to in this section as
the ``task force'') which shall--
(A) design, implement, and evaluate the education,
prevention, and treatment practices and strategies of
the Federal Government with respect to Ecstasy, MDMA,
and emerging club drugs; and
(B) specifically study the club drug problem and
report its findings to Congress.
(2) Membership.--The task force shall--
(A) be under the jurisdiction of the Director of
the Office of National Drug Control Policy, who shall
designate a chairperson; and
(B) include as members law enforcement, substance
abuse prevention, judicial, and public health
professionals as well as representatives from Federal,
State, and local agencies.
(b) Responsibilities.--The responsibilities of the task force shall
be--
(1) to evaluate the current practices and strategies of the
Federal Government in education, prevention, and treatment for
Ecstasy, MDMA, and other emerging club drugs and recommend
appropriate and beneficial models for education, prevention,
and treatment;
(2) to identify appropriate government components and
resources to implement task force recommendations; and
(3) to make recommendations to the President and Congress
to implement proposed improvements in accordance with the
National Drug Control Strategy and its budget allocations.
(c) Meetings.--The task force shall meet at least once every 6
months.
(d) Termination.--The task force shall terminate 3 years after the
date of enactment of this Act.
(e) Authorization of Appropriations.--There are authorized to be
appropriated $1,000,000 to carry out this section.
<all>